Back to search

Article

Docetaxel HIPEC Combined with Endostar versus Docetaxel HIPEC Alone in Treatment of Malignant Ascites:A Retrospective Study

2021-03-22

Abstract excerpt

<title>Abstract</title> <p><bold>Objective:</bold>The purpose of this study is to retrospectively observe the clinical efficacy and adverse reactions of docetaxel hyperthermic intraperitoneal chemotherapy (HIPEC) combined with endostar in treatment of malignant ascites. <bold>Methods:</bold>56 cases of malignant ascites admitted to Zhejiang Hospital from July 2019 and October 2020 had received no less than second...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
5e16f679-af52-5ba7-afb6-3a45d3d5b63d
DOI
10.21203/rs.3.rs-306501/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Docetaxel HIPEC Combined with Endostar versus Docetaxel HIPEC Alone in Treatment of Malignant Ascites:A Retrospective StudyDOI 10.21203/rs.3.rs-306501/v1
Select a neighboring publication to make it the new centre.